Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Smith & Nephew plc (SNN) vs Vanguard International High Dividend Yield ETF (VYMI) Price & Performance

Smith & Nephew plcTrade
Vanguard International High Dividend Yield ETFTrade

Price performance (Past 24H)

Key statistics

Smith & Nephew plc vs Vanguard International High Dividend Yield ETF — how do they compare? Smith & Nephew plc trades at $29.77 (market cap $12.54B), while Vanguard International High Dividend Yield ETF trades at $104.49. The key difference: Smith & Nephew plc pays a 2.65% dividend while Vanguard International High Dividend Yield ETF pays none, and Vanguard International High Dividend Yield ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.

SNNVYMI
Market Cap
$12.54B
Sector
HealthBroad Market / Factor
52-Week High
$38.70$105.05
52-Week Low
$28.73$82.92
Enterprise Value
$15.57B
Dividend Yield
2.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Smith & Nephew plc

Smith & Nephew (SNN) trades at $29.76, down 1.06% with bearish technical signals. The company shows improving fundamentals with revenue growth from $5.8B to $6.2B and net income margin expanding to 10.08% in 2025. Recent Q2 2026 earnings beat expectations but the company lowered full-year revenue guidance from 6% to 4% growth due to U.S. Orthopaedics weakness.

While valuation multiples appear reasonable (P/E 20.41, EV/EBITDA 9.9), the stock faces headwinds from mixed earnings performance and cautious analyst sentiment. The primary investment case hinges on execution in robotics and wound care segments offsetting orthopedic challenges, with downside risk from continued U.S. market softness.

Vanguard International High Dividend Yield ETF

VYMI trades at $104.69, up 0.1% on the day, with strong technical momentum as it approaches resistance at $105. The ETF has gained attention for its international dividend strategy, offering a 3.4% yield and delivering 55% total returns since previous coverage. Recent institutional buying and positive media sentiment highlight growing investor interest in international high-yield exposure.

The outlook remains positive given Vanguard's projection of international developed-market stocks outperforming US markets over the next decade. Key opportunities include diversification benefits and strong dividend growth, while risks center on currency fluctuations and global economic volatility. The ETF's technical strength and fundamental appeal support a constructive view for income-focused investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN

About Vanguard International High Dividend Yield ETF

VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.

Read more on VYMI